ReviewIndian dermatology online journal
Current Situation of Leprosy in India and its Future Implications.
Review in Indian dermatology online journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
62 citing papers in PubMed, 1 synthesis or guideline pooled it, 188 citations in OpenAlex.
- Prevalence of paucibacillary cases of leprosy in Brazil: a 20-year systematic review and meta-analysis.Frontiers in medicine · 2024Pooled it
- Unveiling the impact of the COVID-19 pandemic on quality indicators of leprosy services in Brazil: an ecological study.BMC health services research · 2026Article
- Lepromatous Leprosy Mimicking Sarcoidosis With Elevated Serum ACE Levels: A Deceptive Granulomatous Presentation.Cureus · 2026Article
- Human resource challenges in leprosy control: A cross-sectional study in southwest border area of China.PLoS neglected tropical diseases · 2026Article
- Article
- Article
- Article
- Article
- From leprosy to ground zero: Imagining futures in a world of elimination.Medical anthropology quarterly · 2025Article
- Development and Validation of a Questionnaire to Assess Social Perspectives Among Leprosy-Affected Individuals in a Rehabilitation Colony in Pune, Maharashtra, India.Journal of pharmacy & bioallied sciences · 2025Article
- Barriers to seeking healthcare services and contributing factors to grade 2 disability among women affected by leprosy in Telangana, India - a qualitative study.International journal for equity in health · 2025Article
- Leprosy research registry a global perspective: Need of hour for a newer vision in India towards zero leprosy.Indian journal of pharmacology · 2025Article
- Time trend and identification of risk areas for physical disability due to leprosy in Brazil: An ecological study, 2001-2022.BMC infectious diseases · 2025Article
- Rare Mycobacterial Infections in Kidney Transplant Recipients - Case Reports.Indian journal of transplantation · 2025Article
- Uncommon Presentation of Lepromatous Leprosy in a Nonendemic Setting: A Case Report.Case reports in medicine · 2025Article
- Rifampicin and ofloxacin dual therapy as an adjunct to standard MB-MDT in the management of nodulo-ulcerative lepromatous leprosy with histoid-like features: a case report.Frontiers in medicine · 2025Article
- Mental health and stigma in persons affected by Hansen's disease and their families in rural Sitapur, India.PLOS mental health · 2025Article
- Beyond Classic Leprosy: Exploring Atypical Manifestations and Their Diagnostic Challenges.Cureus · 2024Article
- Dr. Indira Nath: Innovator in Leprosy Immunology and a Beacon of Scientific Excellence.Cureus · 2024Review
- Steroid Premedication Might Protect From Postoperative Erythema Nodosum Leprosum in Leprosy: A Case Report.Cureus · 2024Article
2 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The global leprosy situation has changed significantly over the last four decades after the introduction of multidrug therapy (MDT) in 1982 with a reduction in prevalence from over 5 million cases in the mid-1980s to less than 200,000 at the end of 2016. The programme in India also saw a reduction from a prevalence rate of 57.8/10,000 in 1983 to less than 1/10,000 by the end of 2005 when India declared to have reached the World Health Organization (WHO) target of elimination as a public health problem. Post 2005, major changes in the programme were made by the National leprosy eradication programme (NLEP) and the global leprosy programme, which may have affected the new case detection (NCD), disability, and child leprosy trends, which continue to show no appreciable regression. This article reviews the current global and Indian leprosy scenario to bring out its achievements and successes, including the impact of Leprosy Case Detection Campaigns (LCDC) on leprosy numbers. The basis and expected benefits of recent introduction of chemo and immune-prophylaxis in the programme are also discussed. It also discusses the shortcomings, the areas of concern, and the need for an inclusive strategy in the Indian leprosy programme that includes an intersectoral collaboration within the country for reaching the desired goal of leprosy eradication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.